Pharma-Bio Serv (PBSV) Non-Current Debt (2020 - 2021)
Pharma-Bio Serv (PBSV) posted Non-Current Debt of $643900.0 for Q2 2021, little changed on a QoQ basis from $643900.0 in Q1 2021, and down 50.0% year-over-year from $1.3 million in Q2 2020.
Pharma-Bio Serv (PBSV) Non-Current Debt (2020 - 2021) Analysis & Trends
Pharma-Bio Serv's Non-Current Debt history runs 2 years deep, the most recent figure standing at $643900.0 for Q2 2021.
- Quarterly Non-Current Debt fell 50.0% year-over-year to $643900.0 in Q2 2021, while the trailing twelve-month figure through Apr 2021 was $643900.0 (down 50.0% YoY) and the FY2020 annual result came in at $643900.0, changed N/A from the prior year.
- Non-Current Debt was $643900.0 for Q2 2021 at Pharma-Bio Serv, roughly flat from $643900.0 in the prior quarter.
- Across five years, Non-Current Debt topped out at $1.3 million in Q2 2020 and bottomed at $643900.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 32.17 Bn | 24.86 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 14.62 Bn | 13.72 Bn | 482.22 Mn | 2.44 Bn |
| 3 | Healthequity | 8.40 Bn | 8.14 Bn | 256.31 Mn | 942.66 Mn |
| 4 | Hinge Health | 5.95 Bn | 5.63 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 5.86 Bn | 5.32 Bn | 106.18 Mn | - |
| 6 | MiniMed | 4.52 Bn | 4.22 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.46 Bn | 4.40 Bn | 216.84 Mn | 1.46 Bn |
| 8 | Doximity | 3.95 Bn | 3.20 Bn | 125.97 Mn | - |
| 9 | Privia Health | 3.12 Bn | 2.70 Bn | - | - |
| 10 | Pharma-Bio Serv | 13.28 Mn | 4.81 Mn | 902,041.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2021 | 643,900.00 |
| Jan 31, 2021 | 643,900.00 |
| Oct 31, 2020 | 643,900.00 |
| Jul 31, 2020 | 965,850.00 |
| Apr 30, 2020 | 1.29 Mn |